|
International Trials:
Regional Trials:
|
Dear Cooperator:
Since the beginning of 2004, CIMMYT is on
a new strategic course to address the challenges of international
agricultural research in the years to come: the need to bring
about a real improvement in the livelihoods of the poor; the
emerging biophysical, socioeconomic, and political constraints
to agriculture in developing countries; the growing range
of partners involved in research, extension, and development;
and the changing financial landscape for public-sector research.
A Quick Guide to the new CIMMYT can be found on www.cimmyt.org/english/docs/special_publ/quickGuide.htm.
Not all things at
CIMMYT will change, however. CIMMYT will continue to be the
caretaker of the World's genetic resources for maize and wheat,
and a major distributor of maize and wheat germplasm through
international trials and special seed shipments. Next to germplasm,
our network of partners worldwide will remain our most important
asset. It is through this network that CIMMYT germplasm gets
evaluated, released and new varieties benefit farmers world-wide.
Your feed-back assists us in further improving our products
and better meeting yours and farmers' needs. Anybody can use
CIMMYT germplasm for research purposes and, with permission
from CIMMYT and following country-specific laws and regulations,
register it for commercialization. As it is the trials that
you grow that establish the value of CIMMYT germplasm, you
can be as proud as we are when CIMMYT germplasm is released
and benefits farmers in your country.
This is a single consolidated announcement
for CIMMYT maize trials from Mexico, Colombia, Kenya and Zimbabwe.
The trials contain new hybrids and open-pollinated varieties
(OPVs) improved for broad adaptation, high yield potential
and for tolerance/resistance to prevalent abiotic and biotic
stresses...........
|
